Ethical Issues in Trialling and Using a Cocaine Vaccine to Treat and Prevent Cocaine Dependence
Overview
This project was commissioned by the World Health Organization for a report on ethical issues raised by neuroscience research on the addictions. The most promising application of a cocaine vaccine is to prevent relapse to dependence in abstinent users. The project discusses the role a cocaine vaccine could play in relapse prevention and the ethical issues its use raises for voluntary users; its use as a legally coercive treatment strategy for dependent users; and the potential use of a cocaine vaccine for dependence prevention purposes in children and adolescents.
OPPE Staff
Wayne Hall and Lucy Carter
Status
Comission completed
Outcomes
A paper has been published
in a peer-reviewed journal:
Hall, W. & Carter L. (2003) Ethical issues in using
a cocaine vaccine to treat and prevent cocaine abuse and dependence, Journal
of Medical Ethics, in press.
The material in the
paper is also available as a Technical Report published by the National
Drug and Alcohol Research Centre, University of New South Wales:
Hall, W. & Carter L. (2002) Ethical issues in trialling and using
a cocaine vaccine to treat and prevent cocaine dependence. Sydney: National
Drug and Alcohol Research Centre.
Funding
Contact webmaster: oppe@uq.edu.au
Last updated: 9 July
2003